Focus Stocks
IntegraMed® to Present on Singular Research’s "Compelling Values" Webcast Wed., Sept. 15th at Noon ET
Published on Wednesday, 08 September 2010 08:41 Written by TradersHuddle Staff
PURCHASE, N.Y.-( Business Wire )-IntegraMed America, Inc. (NASDAQ: INMD), the leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, today announced that its CEO, Jay Higham, and its CFO, John Hlywak, will review the Company’s business and strategy on Singular Research’s "Compelling Values" webcast on Wednesday, September 15th at Noon ET.
|
Conference Call: |
Wednesday, September 15, 2010 at Noon ET | |
|
Webcast / Replay URL: |
http://www.singularresearch.com “Special Report” or IntegraMed - Investor Relations - Investor's Overview. The replay will be available online for approximately 30 days. |
|
|
|
||
About Singular Research
Singular Research, winner of the “2008 Top Performers Award” from First Coverage, aims to be the most trusted supplier of independent research on small-cap companies. Singular’s Analysts have won several five star ratings from StarMine for earnings accuracy. Independent analysts research high-quality companies that are typically not covered by other firms and they have no financial interest in the stocks they cover. Analysts are compensated based on the accuracy of their research calls, not through trading commissions or investment banking fees. For more information visit: www.singularresearch.com.
About IntegraMed America, Inc.
IntegraMed is a leader in developing, marketing and managing specialty outpatient healthcare facilities, with current focus on the fertility and vein care markets. IntegraMed supports its provider networks with clinical and business information systems, marketing and sales, facilities and operations management, finance and accounting, human resources, legal, risk management, quality assurance, and fertility treatment financing programs. IntegraMed’s Attain Fertility Centers network is the nation’s largest, with 14 company-managed partner centers and 27 affiliate centers, comprising over 125 locations across 34 states and the District of Columbia. Nearly one of every four IVF procedures in the U.S. is performed in an IntegraMed Attain Fertility Center or in an affiliate practice. The IntegraMed Vein Clinic network is the leading provider of specialty vein care services in the U.S., operating 36 centers across 13 states, principally in the Midwest and Southeast.
For more information about IntegraMed please visit:
www.integramed.com
for investor background,
www.attainfertility.com
for fertility, or
www.veinclinics.com
for vein care
Related Articles
- Specialty Healthcare Services Provider, IntegraMed America to Host Q4 Conference Call Thursday, February 16th at 10:00 A.M. ET
- IntegraMed to Present at the Oppenheimer Healthcare Conference on Wednesday, Dec. 14th at 2:10 p.m. ET
- IntegraMed to Present at the Piper Jaffray Healthcare Conference on Wednesday, Nov. 30th at 11:00 a.m. ET
Related Partner Headlines
- IntegraMed America Inc. Stock Upgraded (INMD) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
UPDATE: Canaccord Genuity Raises Target on Apple to 5 - Benzinga -
How to Profit off Addicts - Benzinga -
UPDATE: DA Davidson Upgrades Powell Industries to Buy - Benzinga -
Did Sununu Seek Jobs for a Presidential Appointment? - TheStreet.com -
UPDATE: DA Davidson Upgrades Consolidated Communications to Neutral - Benzinga -
Arthur J. Gallagher Reaches New 52-Week High (AJG) - TheStreet.com -
UPDATE: Wedbush Raises Target on Visa to - Benzinga -
Notable Call Options Activity in Southwestern Energy - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,911.39 Trade time:2:03PM EST Value change:▲27.44 (0.21%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,353.67 Trade time:2:03PM EST Value change:▲3.71 (0.27%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,928.26 Trade time:2:03PM EST Value change:▲12.40 (0.43%)In The Wires
-
FDA’s Oncologic Drugs Advisory Committee (ODAC) Votes to not Support Benefit/Risk Profile of DACOGEN® (decitabine) in Acute Myeloid Leukemia -
Boston Financial Introduces Financial Intermediary Administration Solution -
'Common Sense' Immigration Policy Recommended by Md. State Panel -
Study Shows Boomers Are Still More Likely Than Gen Y to Purchase Health, Beauty, Food, and Beverage Products Online -
EyeCity.com, Inc. Releases Shareholder Updates Regarding Acquisition Strategy for 2012 -
Brad's Deals Releases Top Valentine's Day Deals and Coupon Codes -
Spirit Airlines Starts Service Between Phoenix-Mesa and Las Vegas -
CUSIP ID Requests Project Steady Pace for US Corporate and Muni Debt Issuance in Q1










